Cite
HARVARD Citation
Kashyap, A. et al. (2019). Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity. Journal for immunotherapy of cancer. 7 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kashyap, A. et al. (2019). Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity. Journal for immunotherapy of cancer. 7 (1), p. . [Online].